Storys zum Thema Science

Folgen
Keine Story zum Thema Science mehr verpassen.
Filtern
  • 15.12.2008 – 15:00

    DNArtistic and Inneova Corporation Limit

    DNA Jewel to Finance Anti-Aging Services & Cancer Research

    Geneva (ots) - Swiss-based www.dnartistic.com 's first piece of DNA luxury jewellery will be sold at 1 million CHF and some of the proceeds will be used to finance the anti-aging services and life extension research of sister company www.inneova.com. Dr. Ivan de Weber, a young Swiss scientist specialized in molecular genetics of aging and co-founder of both Inneova™ and DNArtistic has brought together a group of ...

  • 13.10.2008 – 10:00

    Solianis Monitoring AG

    Convincing results of Solianis' multisensor system in home-use trial

    Zurich, (ots) - Solianis' multisensor system for non-invasive Continuous Glucose Monitoring is currently being tested by diabetic patients in the home and work environment. 12 patients have completed a 10-day trial aimed at assessing system reliability. Results indicate that the system tracks glucose in home-use settings and is sensitive to hypoglycemic glucose ...

  • 11.09.2008 – 14:15

    Novozymes Switzerland AG

    Cut your ingredient costs with Novozymes' Lipopan® Xtra and Lipopan® F

    Dittingen, Switzerland (ots) - Throughout recent times, consumer tastes have been honed to enjoy a wide variety of quality bread products. But manufacturers are posed with an escalating dilemma - how to counteract the ever-rising ingredient prices with cost-effective alternatives that ensure bread improvement. With bread remaining an important element in daily diets ...

  • 05.09.2008 – 11:00

    European Society for Medical Oncology (ESMO)

    33rd ESMO Congress in Stockholm, 12-16 September 2008

    Lugano (ots) - The 33rd ESMO Congress in Stockholm, the premier European congress in Oncology, serves as a meeting place for medical oncologists, as well as a focal point to exchange ideas with colleagues from other disciplines. The Congress Centre will be the venue for interdisciplinary interaction, a teaching ground, and a place to discuss critical issues for European oncology such as cancer research in Europe, the ...

  • 12.06.2008 – 08:50

    AmVac AG

    AmVac AG Begins Research Cooperation with Bayer

    Zug, Catania (ots) - AmVac AG, a Swiss biopharmaceutical company based in Zug, is starting its first research cooperation program with Bayer Innovation GmbH on the development of a new influenza vaccine. Joint research and development work is beginning with the Bayer subsidiary Icon Genetics GmbH on a novel production approach. Antigens are to be produced for the first time in tobacco plants which along with AmVac AG's ...